Alger Health Sciences Fund Class C AHSCX

Morningstar Medalist Rating
  • NAV / 1-Day Return$18.59  /  −0.38%
  • Fund Size$96.1M
  • Adjusted Expense Ratio1.960%
  • Net Expense Ratio1.960%
  • Fee Level: DistributionAverage
  • Share Class TypeLevel Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Mid Blend
  • Minimum Initial Investment$1,000
  • Investment StatusOpen
  • TTM Yield0.00%
  • Turnover Ratio289%

Morningstar’s Analysis AHSCX

Will AHSCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Alger Health Sciences C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings AHSCX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings40.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Merck & Co Inc

5.905M
Healthcare

Cash

5.355M
Cash and Equivalents

Becton Dickinson & Co

4.924M
Healthcare

Welltower Inc

4.264M
Real Estate

Thermo Fisher Scientific Inc

3.813M
Healthcare

Boston Scientific Corp

3.813M
Healthcare

Impulse Dynamics

3.783M
—

Johnson & Johnson

3.753M
Healthcare

Illumina Inc

3.593M
Healthcare

Repligen Corp

3.203M
Healthcare

Sponsor Center